TCM
AZN icon

Tradewinds Capital Management’s AstraZeneca AZN Stock Holding History

Tradewinds Capital Management’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-160
Closed -$24.9K – 672
2024
Q3 		$24.9K Hold
160
– – 0.01% 247
2024
Q2 		$25K Buy
160
+30
+23% +$4.51K 0.01% 229
2024
Q1 		$17.6K Buy
+130
New +$17.2K ﹤0.01% 244
2016
Q4 		– Sell
-125
Closed -$8K – 633
2016
Q3 		$8K Buy
125
+25
+25% +$1.63K 0.01% 391
2016
Q2 		$6K Hold
100
– – ﹤0.01% 419
2016
Q1 		$6K Hold
100
– – ﹤0.01% 442
2015
Q4 		$7K Buy
+100
New +$6.56K 0.01% 414

Other funds holding AZN

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Sanders Capital
Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return

Tradewinds Capital Management's AZN Position: Q4 2024 in Review

Tradewinds Capital Management sold out of AstraZeneca (AZN) in Q4 2024, closing a stake of 160 shares — an estimated $24.9K sold.

Tradewinds Capital Management first reported a position in AZN in Q4 2015 and held it in 7 quarters. The position peaked at $25K in Q2 2024. 1,220 funds tracked by Wall St. Rank hold AZN as of Q4 2024.

  • Tradewinds Capital Management reported no remaining AstraZeneca position as of Q4 2024 after selling out during the quarter.
  • Tradewinds Capital Management sold 160 AstraZeneca shares in Q4 2024, an estimated $24.9K.
  • Tradewinds Capital Management first reported a position in AstraZeneca in Q4 2015 and held it in 7 quarters.
  • Tradewinds Capital Management's AstraZeneca position peaked at $25K in Q2 2024.
  • 1,220 funds tracked by Wall St. Rank held AstraZeneca as of Q4 2024.

Based on Tradewinds Capital Management's 13F filing for Q4 2024, filed 4 Feb 2025.